Raloxifene Hydrochloride

Product NDC
71335-1663
11-digit product format
713351663
Labeler code
71335
Product ID
71335-1663_ac4f5eb7-441c-4b01-bbce-71d5c118bfa0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Raloxifene
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA090842
Marketing category
ANDA
Marketing start
2016-06-29
Marketing end
0000-00-00
Substance
RALOXIFENE HYDROCHLORIDE
Active strength
60 mg/1
Pharmacologic classes
Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
7ad62b49-6132-2a8c-4edd-73f39b2bf45cProduct name620210312

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
71335-1663-1Raloxifene Hydrochloride60 in 1 BOTTLETABLET602
71335-1663-2Raloxifene Hydrochloride30 in 1 BOTTLETABLET302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
71335-1663RALOXIFENE HYDROCHLORIDE (RALOXIFENE) TABLET [BRYANT RANCH PREPACK]2Legacy NDC, 2 package rows20221202_ae557c81-e206-47fd-881e-b8f7fca2a3b0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1490065raloxifene HCl 60 MG Oral TabletPSNae557c81-e206-47fd-881e-b8f7fca2a3b02
1490065raloxifene hydrochloride 60 MG Oral TabletSCDae557c81-e206-47fd-881e-b8f7fca2a3b02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71335-1663-17133516630160 TABLET in 1 BOTTLE (71335-1663-1) 60 tablet2020-07-150000-00-00NoNoCurrent
71335-1663-27133516630230 TABLET in 1 BOTTLE (71335-1663-2) 30 tablet2020-07-150000-00-00NoNoCurrent